The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome.
Burnett AK, Hills RK, Hunter A, Milligan D, Kell J, Wheatley K, Yin J, McMullin MF, Cahalin P, Craig J, Bowen D, Russell N.
Burnett AK, et al. Among authors: wheatley k.
Leukemia. 2011 Jul;25(7):1122-7. doi: 10.1038/leu.2011.59. Epub 2011 Apr 8.
Leukemia. 2011.
PMID: 21475252
Free PMC article.
Clinical Trial.